IGF1 and obstructive sleep apnea syndrome: Plasma IGF-1 concentrations in patients with OSAHS were reduced compared with those of subjects in the control group (SMD=-2.12, 95 percent CI= -3.89–0.34, P=0.019), according to a subgroup analysis of cross-sectional studies.